St. Louis, MO, United States of America

Michael J Hayes

USPTO Granted Patents = 7 

Average Co-Inventor Count = 16.4

ph-index = 3

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
7 patents (USPTO):Explore Patents

Sure, I can help you with that. Here is an article about inventor Michael J Hayes:

Title: The Innovation Journey of Michael J Hayes

Introduction:

Michael J Hayes, based in St. Louis, MO (US), is a prolific inventor with an impressive portfolio of 7 patents to his name. His groundbreaking work has significantly impacted the field of anticoagulant therapy and the treatment of thrombotic conditions.

Latest Patents:

1. Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade - This invention focuses on compounds that serve as inhibitors of serine proteases within the coagulation cascade, offering a promising avenue for anticoagulant therapy in various thrombotic conditions.

2. Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade - Hayes' work in this patent centers on compounds that selectively inhibit proteases involved in the coagulation cascade, presenting novel approaches to preventing and treating thrombotic conditions in mammals.

Career Highlights:

Throughout his career, Michael J Hayes has made significant contributions to the field of pharmacology and drug development. He has worked with renowned companies such as Pharmacia Corporation and Warner-Lambert Company, where his innovative research has paved the way for advancements in anticoagulant therapy.

Collaborations:

Hayes has had the privilege of collaborating with talented individuals in the industry, including coworkers Brenda Case and Horng-Chih Huang. These collaborations have fostered a dynamic exchange of ideas and expertise, leading to the successful development of novel treatments in the realm of thrombosis management.

Conclusion:

In conclusion, Michael J Hayes stands as a visionary inventor whose pioneering work in anticoagulant therapy has reshaped the landscape of pharmacology. His dedication to innovation and commitment to advancing medical science continue to inspire future generations of inventors in the quest for groundbreaking discoveries in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…